V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10322775 | 10039549 | 1.68 | 100.1 | Palliative (P) | 2017-05-10 | 2017-05-23 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 100403051 |
| 10322797 | 10039550 | 1.76 | 71.75 | 03 | 2018-03-10 | 2018-03-16 | FEC 100 + DOCETAXEL | 02 | N | TRIAL | 100440462 |
| 10322806 | 10039551 | 1.64 | 81.1 | Neo-adjuvant (N) | 2014-09-11 | 2014-09-12 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 100070307 |
| 10322848 | 10039552 | 1.67 | 69.75 | 03 | 2018-12-10 | 2018-12-10 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101343903 |
| 10322934 | 10039554 | 0 | null | null | 2019-01-04 | 2019-01-10 | CHOP R - 21 days | 02 | Y | CHOP R | 100119265 |
| 10322935 | 10039555 | 1.7 | 85.8 | Palliative (P) | 2018-11-10 | 2018-12-15 | Fluorouricil + Folonic Acid (MdG) | N | N | FLUOROURACIL | 101312925 |
| 10322997 | 10039557 | null | 59 | Adjuvant (A) | 2016-04-04 | 2016-04-07 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100268855 |
| 10323004 | 10039558 | 1.71 | null | Palliative (P) | 2019-02-15 | 2019-02-17 | CHLORAMBUCIL + RITUXIMAB | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100673972 |
| 10323051 | 10039559 | 1.64 | 49.3 | 03 | 2016-08-11 | 2016-11-19 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101703004 |
| 10323152 | 10039562 | 1.69 | 65 | Curative (C) | 2016-07-30 | 2016-08-13 | Venetoclax | 02 | N | PAZOPANIB | 100164694 |
| 10323303 | 10039564 | null | 85 | null | 2016-12-17 | 2016-12-22 | CARBOPLATIN + VINORELBINE | 02 | null | CARBOPLATIN + VINORELBINE | 101109556 |
| 10323346 | 10039566 | 1.6 | 95 | Palliative (P) | null | 2021-12-01 | POMALIDOMIDE | N | N | CISPLATIN + VINORELBINE | 100165536 |
| 10323380 | 10039567 | 1.7 | 88 | null | null | 2022-02-28 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101324499 |
| 10323398 | 10039568 | 1.54 | 0 | 03 | null | 2019-10-29 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101128859 |
| 10323400 | 10039569 | 1.57 | 0 | Curative (C) | 2018-08-20 | 2018-08-21 | CAPECITABINE + GEMCITABINE | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100231808 |
| 10323436 | 10039570 | 1.63 | null | null | 2019-02-13 | 2019-02-27 | Temozolomide + RT | 02 | null | TEMOZOLOMIDE | 101001183 |
| 10323478 | 10039571 | 1.72 | 71.55 | Curative (C) | 2017-06-05 | 2017-06-12 | DABRAFENIB + TRAMETINIB | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101080308 |
| 10323608 | 10039572 | null | 0 | 03 | 2019-11-12 | 2019-11-13 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100651319 |
| 10323770 | 10039574 | 1.68 | 77.2 | Palliative (P) | 2018-05-26 | 2018-05-26 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101825349 |
| 10323777 | 10039575 | 1.62 | 78 | Curative (C) | 2017-09-20 | 2017-09-20 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101309182 |
| 10323806 | 10039576 | 1.66 | 75.3 | Adjuvant (A) | 2017-10-29 | 2017-10-29 | Avelumab | 02 | N | AVELUMAB | 100110497 |
| 10323911 | 10039577 | 1.75 | 107 | 03 | 2017-07-25 | 2017-07-25 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100977410 |
| 10323958 | 10039578 | null | null | null | 2019-12-08 | 2019-12-25 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100254515 |
| 10324013 | 10039580 | 1.78 | 79.6 | Palliative (P) | 2018-06-10 | 2018-06-12 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100317118 |
| 10324034 | 10039581 | 1.6 | 67.5 | Palliative (P) | 2019-01-29 | 2019-01-30 | CHLORAMBUCIL + RITUXIMAB | N | N | CHLORAMBUCIL + RITUXIMAB | 100378987 |
| 10324052 | 10039582 | 1.71 | 65.4 | 03 | 2017-04-20 | 2017-04-20 | Cyclophosphamide + Docetaxel | 02 | null | CISPLATIN + VINORELBINE | 100451763 |
| 10324055 | 10039583 | 1.8 | 67.5 | Palliative (P) | 2021-04-08 | 2021-04-23 | DARATUMUMAB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100785538 |
| 10324065 | 10039584 | null | null | null | 2021-12-11 | 2021-12-24 | NIVOLUMAB | null | null | NIVOLUMAB | 101110343 |
| 10324117 | 10039585 | 1.76 | 50.2 | null | 2019-11-22 | 2019-12-04 | Acalabrutinib | 02 | null | ACALABRUTINIB | 101423585 |
| 10324217 | 10039586 | 1.6 | 58.9 | 03 | 2017-05-11 | 2017-08-08 | Cytarabine Low Dose | 02 | null | DABRAFENIB + TRAMETINIB | 101330370 |
| 10324228 | 10039587 | 1.39 | 82.3 | Neo-adjuvant (N) | 2019-12-08 | 2019-12-28 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101693794 |
| 10324266 | 10039588 | 0 | 0 | Curative (C) | null | 2019-08-11 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101469887 |
| 10324285 | 10039590 | 1.79 | 95.1 | Palliative (P) | 2018-01-12 | 2018-01-13 | Pazopanib | 02 | N | CAPECITABINE + CISPLATIN | 100662287 |
| 10324344 | 10039591 | 1.48 | 61.6 | Palliative (P) | 2019-02-14 | 2019-02-18 | Cisplatin + Vinorelbine (IV) | null | N | CAPECITABINE + GEMCITABINE | 100453548 |
| 10324364 | 10039592 | 1.73 | 54.6 | Palliative (P) | 2017-09-19 | 2017-09-20 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | POMALIDOMIDE | 101315967 |
| 10324397 | 10039593 | 1.86 | 78.6 | Palliative (P) | 2017-04-17 | 2017-05-02 | Avelumab | 02 | null | AVELUMAB | 101632972 |
| 10324499 | 10039595 | 1.6 | 83 | null | 2019-03-31 | 2019-04-07 | Avelumab | 02 | null | AVELUMAB | 100484059 |
| 10324586 | 10039598 | 1.69 | 108.3 | 03 | 2019-10-19 | 2019-10-20 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 100475241 |
| 10324734 | 10039601 | null | 53 | Curative (C) | 2019-01-21 | 2019-01-21 | EOX | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100496987 |
| 10324762 | 10039603 | null | 0 | Curative (C) | 2019-11-25 | 2019-11-25 | DARATUMUMAB | 02 | null | CAPECITABINE + CISPLATIN | 100311553 |
| 10324770 | 10039604 | null | 79 | Adjuvant (A) | 2016-07-29 | 2016-08-11 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100775461 |
| 10324771 | 10039605 | 1.66 | 86.7 | 03 | 2019-04-27 | 2019-05-24 | null | 02 | N | SUNITINIB | 100514049 |
| 10324828 | 10039606 | 1.52 | 62.5 | null | 2021-09-30 | 2021-09-30 | Cyclophosphamide + Dex + Rituximab | 2 | null | BCG | 100499158 |
| 10324881 | 10039608 | 1.82 | 80.8 | Adjuvant (A) | 1995-02-25 | 2016-12-30 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | CVP R | 101724138 |
| 10324882 | 10039609 | 1.81 | 78.6 | null | 2021-10-15 | 2021-10-31 | Venetoclax | 2 | null | POMALIDOMIDE | 100530100 |
| 10324889 | 10039610 | 1.82 | 92.7 | null | 2021-12-10 | 2021-12-15 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101262419 |
| 10324922 | 10039611 | 1.75 | 63.2 | Curative (C) | 2018-09-11 | 2018-10-01 | CAPECITABINE + GEMCITABINE | null | N | SUNITINIB | 101164458 |
| 10324935 | 10039612 | 1.75 | 73 | Palliative (P) | 2017-05-02 | 2017-05-27 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101175091 |
| 10324946 | 10039613 | 1.7 | 69.8 | null | 2022-01-28 | 2022-02-22 | Avelumab | 2 | null | AVELUMAB | 100488722 |
| 10324968 | 10039614 | 1.74 | 73.5 | 03 | 2021-12-12 | 2021-12-12 | CYTARABINE | 02 | N | CLADRIBINE | 100986312 |